Neuropeptides
Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial
Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z; CASTA Investigators. · Stroke · 2012
PMID: 22282884 · DOI: 10.1161/STROKEAHA.111.628347
Summary
Multicenter double-blind randomized placebo-controlled trial (CASTA) of intravenous cerebrolysin within 12 h of acute ischemic stroke in Asia. Endpoints: composite NIHSS, mRS, Barthel at day 90.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
More Neuropeptides citations
- Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled TrialsNeurol Sci · 2018
- Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurastheniaZh Nevrol Psikhiatr Im S S Korsakova · 2007
- The efficacy of semax in the treatment of patients at different stages of ischemic strokeZh Nevrol Psikhiatr Im S S Korsakova · 2018